Post-infection symptoms up to 24 months after COVID-19: a matched cohort study in Berlin, Germany
- PMID: 40145003
- PMCID: PMC11937017
- DOI: 10.3389/fpubh.2025.1513664
Post-infection symptoms up to 24 months after COVID-19: a matched cohort study in Berlin, Germany
Abstract
Introduction: Long-term health consequences after mild COVID-19 are not well described. Our aim was to estimate their prevalence and describe the time course of signs and symptoms for a period of up to 24 months after SARS-CoV-2 infection.
Methods: We conducted a cohort study matched for age, sex, and test week among individuals who had attended the public COVID-19 test center at Charité-Universitätsmedizin Berlin, Germany. In early 2022, 576 former COVID-19 patients (>95% non-hospitalized) and 302 uninfected individuals responded to a questionnaire on retrospective monthly symptoms since the test date up to 24 months ago.
Results: Symptoms compatible with long COVID were present in 42.9% (247/576) of former COVID-19 patients, compared with 21.2% (64/302) in the uninfected group. In former patients, unadjusted odds ratios (OR) were highest for disturbed taste/smell (OR 9.1 [95% CI: 4.0-21.1]), memory difficulties (OR 5.1 [95% CI: 2.9-8.9]), and shortness of breath at rest (OR 4.5 [95% CI: 1.9-10.6]). In most former COVID-19 patients, symptoms occurred in one coherent period and resolved after a median of 6.5 months, while taste/smell disturbance and neurological/cognitive symptoms showed longer times until recovery. Factors associated with long COVID-compatible symptoms included hospitalization, symptomatic COVID-19 infection, low household income and female sex.
Conclusion: Post-infection symptoms in mild COVID-19 patients mostly persist for about half a year, but sometimes longer. Among uninfected individuals who never experienced COVID-19, 21.2% also reported long COVID-compatible symptoms. The current long COVID definition might require revision to prevent misclassification and over-reporting, and to improve diagnosis and prevalence estimates.
Keywords: COVID-19; SARS-CoV-2; long COVID; post COVID-19 condition; post-acute sequel of COVID-19.
Copyright © 2025 Meierkord, Schulze, Gertler, Seybold, Mall, Kurth, Mockenhaupt and Theuring.
Conflict of interest statement
Outside of this work, TK reported receiving research grants from the German Federal Joint Committee (G-BA) and the Federal Ministry of Health (BMG). He reported receiving personal compensation from Eli Lilly & Company, the BMJ, and Frontiers. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Carlilea O, Briggsa A, Hendersona AD, Butler-Coleb BF, Tazarea J, Tomlinsona LA, et al. . Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT). Open access. (2024) 40:100908. doi: 10.1016/j.lanepe.2024.100908, PMID: - DOI - PMC - PubMed
-
- O'Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al. . The prevalence and long-term health effects of long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine. (2023) 55:101762. doi: 10.1016/j.eclinm.2022.101762, PMID: - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
